Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

IntraLinks Announces New Tool for Life Sciences Data Capture and Submission-Based Business

Wed. November 04, 2009; Posted: 09:01 AM
Stocks RSS
NEW YORK, NY, Nov 04, 2009 (MARKETWIRE via COMTEX) -- ADBE | Quote | Chart | News | PowerRating -- IntraLinks(R), the leading provider of critical information exchange solutions, today announced a strategic partnership with Adobe Systems Inc. to develop comprehensive solutions that will automate cross-organization data capture and submission based-business processes within the life sciences industry.

The initial solution IntraLinks and Adobe are bringing to market addresses the document-intensive clinical trial process. The solution combines the strengths of IntraLinks' solutions, which facilitate the secure, compliant, and auditable exchange of critical information inside and outside the enterprise, and the Adobe(R) LiveCycle(R) Enterprise Suite (ES). The new tool provides clinical trial managers with a single, tightly-integrated platform to first conduct electronic data capture and then securely manage, organize and share content across firewalls with sponsors, CROs and investigative sites.

Specifically, the joint solution will help improve workflow during the site recruitment and study start-up phases of a clinical trial. Once an electronic form is created using LiveCycle ES, IntraLinks' validated platform manages the external workflow to organize, distribute, collect, and track e-forms across the firewall with email notifications and an easy "one-click to submit" process for the e-form. LiveCycle ES completes the process by automatically retrieving the completed forms from IntraLinks and routing them through an internal review and approval process.

"Building on Adobe's LiveCycle ES, IntraLinks will leverage its secure and auditable information exchange platform to create a truly paperless solution for the clinical trials process," said Alison Shurell, vice president of marketing for IntraLinks. "This new platform replaces inefficient and non-secure methods of sharing sensitive clinical trial documents such as email, fax and courier."

"Life sciences professionals who already depend on Adobe's LiveCycle ES for data capture and submission based processes will now have a comprehensive solution for document-centric workflows," said Melonie Warfel, director Worldwide Standards & Life Sciences for Adobe Systems Inc. "Together, Adobe and IntraLinks will work to make clinical trial management an efficient, paper-free process."

About IntraLinks

IntraLinks provides on-demand solutions for businesses to securely collaborate, communicate and exchange critical information inside and outside the enterprise. For more than a decade, 750,000 professionals from more than 90,000 organizations have relied on IntraLinks to accelerate workflow, optimize business processes and realize new profit potential. IntraLinks counts 800 of the Fortune 1000 as clients, including AstraZeneca Pharmaceuticals LP, Bank of America, Deutsche Bank and the FDIC. Visit www.intralinks.com or http://blog.intralinks.com for more information.

About Adobe LiveCycle(R)

Adobe LiveCycle(R) ES (Enterprise Suite) software is an integrated server solution that provides integrated data capture, information assurance, document output, process management, and content services to help enterprises create and deliver rich and engaging applications that reduce paperwork, accelerate decision-making, and help ensure regulatory compliance.

CONTACT:
Alison Koski
Text100
212-331-8436
AlisonK@text100.com

Isa Loundon
IntraLinks
212-342-7508
iloundon@intralinks.com


SOURCE: IntraLinks

mailto:AlisonK@text100.com
mailto:iloundon@intralinks.com
For full details on Adobe Systems Inc (ADBE) click here. Adobe Systems Inc (ADBE) has Short Term PowerRatings of 5. Details on Adobe Systems Inc (ADBE) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [ADBE]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.